These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of infections caused by gram-negative bacilli: the role of antimicrobial combinations. Allan JD; Moellering RC Rev Infect Dis; 1985; 7 Suppl 4():S559-71. PubMed ID: 3909313 [TBL] [Abstract][Full Text] [Related]
3. Antimicrobial combinations in the therapy of infections due to gram-negative bacilli. Allan JD; Moellering RC Am J Med; 1985 Feb; 78(2A):65-76. PubMed ID: 3918445 [TBL] [Abstract][Full Text] [Related]
5. Concept of empiric therapy with antibiotic combinations. Indications and limits. Klastersky J Am J Med; 1986 May; 80(5C):2-12. PubMed ID: 3521271 [TBL] [Abstract][Full Text] [Related]
6. Bactericidal synergism between beta-lactams and aminoglycosides: mechanism and possible therapeutic implications. Davis BD Rev Infect Dis; 1982; 4(2):237-45. PubMed ID: 7051225 [TBL] [Abstract][Full Text] [Related]
7. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms. Moellering RC; Eliopoulos GM; Allan JD Am J Med; 1986 May; 80(5C):30-4. PubMed ID: 3717186 [TBL] [Abstract][Full Text] [Related]
8. [Ertapenem]. Gobernado M; Acuña C Rev Esp Quimioter; 2007 Sep; 20(3):277-99. PubMed ID: 18080025 [No Abstract] [Full Text] [Related]
9. Bacterial resistance to beta-lactams, and its prevention with combination antimicrobial therapy. Barriere SL Pharmacotherapy; 1992; 12(5):397-402. PubMed ID: 1437700 [TBL] [Abstract][Full Text] [Related]
10. Bactericidal in-vitro activity of beta-lactams and beta-lactamase inhibitors, alone or associated, against clinical strains of Acinetobacter baumannii: effect of combination with aminoglycosides. Joly-Guillou ML; Decré D; Herrman JL; Bourdelier E; Bergogne-Bérézin E J Antimicrob Chemother; 1995 Oct; 36(4):619-29. PubMed ID: 8591936 [TBL] [Abstract][Full Text] [Related]
11. Approach to the use of antimicrobial combinations. Saag MS Ala J Med Sci; 1985 Jan; 22(1):72-5. PubMed ID: 3883831 [No Abstract] [Full Text] [Related]
12. PS-5, a new beta-lactam antibiotic. III. Synergistic effects and inhibitory activity against a beta-lactamase. Okamura K; Sakamoto M; Fukagawa Y; Ishikura T; Lein J J Antibiot (Tokyo); 1979 Apr; 32(4):280-6. PubMed ID: 381269 [TBL] [Abstract][Full Text] [Related]
13. Rationale for use of antimicrobial combinations. Moellering RC Am J Med; 1983 Aug; 75(2A):4-8. PubMed ID: 6351605 [TBL] [Abstract][Full Text] [Related]
14. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials. Marcus R; Paul M; Elphick H; Leibovici L Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449 [TBL] [Abstract][Full Text] [Related]